Target intelligence / Profile preview

MER1 repeat containing imprinted transcript 1 (MIMT1)

Target
MIMT1
Molecular classification
Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA
01

Overview

MER1 repeat containing imprinted transcript 1 (MIMT1) is a long intergenic non-coding RNA gene located on chromosome 19 in humans[1][7]. MIMT1 undergoes alternative splicing, resulting in at least two transcript variants, and does not encode a protein[1][5]. The gene is imprinted and may regulate the expression of neighboring genes, notably PEG3 and USP29, through a bidirectional promoter mechanism[5]. Microdeletions that disrupt MIMT1 expression are associated with developmental abnormalities in cattle, specifically stillbirth and compromised placental function, likely due to altered imprinting and gene regulation[5]. In humans, MIMT1 is significantly down-regulated in colorectal cancer, suggesting a potential role as a tumor suppressor lncRNA, though its mechanistic functions remain to be confirmed[2]. As a lncRNA, MIMT1 participates in transcriptional and epigenetic regulation but is currently not regarded as a standard therapeutic target, nor does it have known interacting drugs or established mechanisms for pharmacological intervention[1][7].

Other names
MIM1NCRNA00067LINC00067non-protein coding RNA 67long intergenic non-protein coding RNA 67
02

Biological functions

Transcriptional regulation (as a lncRNA, regulates gene expression, possibly through chromatin remodeling and modulation of neighboring genes such as PEG3 and USP29)Epigenetic regulation (potential role in imprinting and chromatin structure maintenance)Alternative splicing (undergoes alternative splicing, influencing transcript variants)
03

Disease associations

Cancer (down-regulated in colorectal cancer, proposed tumor suppressor gene)Developmental disorders (deletions in MIMT1 region associated with stillbirth and placental dysfunction in cattle)
04

Biomarkers

Proposed tumor suppressor/RNA expression level (Potential biomarker for down-regulation in colorectal and possibly other cancers)

Beyond the preview

Go deeper on MER1 repeat containing imprinted transcript 1 (MIMT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MER1 repeat containing imprinted transcript 1 (MIMT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call